For the Inventor, By the Inventor

Enter assignee name

San Mateo, CA, United States of America

Afferent Pharmaceuticals, Inc.

USPTO Granted Patents = 12

CIPO Patents = 1

EPO Patents = 4

Forward Citations = 27

Loading Chart...

Loading Chart...

9 inventors (with patents filed for the assignee):

Anthony P Ford (12 out of 18 patents)

Prabha N Ibrahim (6 out of 134 patents)

Ronald Charles Hawley (6 out of 57 patents)

4. Joel R Gever (4 out of 5 patents)

5. Steven A Smith (3 out of 5 patents)

6. Bruce G McCarthy (3 out of 3 patents)

7. Julian Paton (2 out of 2 patents)

8. Kathleen Sereda Glaub (1 out of 1 patent)

9. Michael M Kitt (1 out of 1 patent)

10. Bruce G Mccarthy (0 patent)

11. Steven Smith (0 patent)

12 patents: Sort by Forward Citations

1. 11260056 - Diaminopyrimidine P2X3 and P2X2/3 receptor modulators for use in the treatment of cough (2022-03-01),

2. 11230533 - Crystalline salts and polymorphs of a P2X3 antagonist (2022-01-25),

3. 11230532 - Pyrimidines and variants thereof, and uses therefor (2022-01-25),

4. 10988460 - Substituted pyrazole-pyrimidines, variants thereof, and uses therefore (2021-04-27),

5. 10822311 - Pyrimidines and variants thereof, and uses therefor (2020-11-03),

6. 10676444 - Crystalline salts and polymorphs of a P2X3 antagonist (2020-06-09),

7. 10662162 - Pyrimidines and variants thereof, and uses therefor (2020-05-26),

8. 10543211 - Methods and compositions for treating diseases and conditions (2020-01-28),

9. 10206922 - Substituted pyrimidines for treatment of chronic cough, neuronal hypersensitivity underlying chronic cough, neuronal hypersensitivity underlying sub-acute cough and neuronal hypersensitivity underlying acute cough (2019-02-19),

10. 10195198 - Methods and compositions for treating diseases and conditions (2019-02-05),

11. 9724346 - Substituted pyrimidines for treatment of a cough selected from chronic pathological cough, sub-acute pathological cough, acute pathological cough, neuronal hypersensitivity underlying chronic cough, neuronal hypersensitivity underlying sub-acute cough and neuronal hypersensitivity underlying acute cough (2017-08-08),

12. 9284279 - Substituted pyrimidines for treatment of acute cough, chronic cough and urge to cough (2016-03-15),

Afferent Pharmaceuticals, Inc. is a pharmaceutical company focused on developing innovative therapeutics for neurogenic inflammatory disorders. With a vision to improve the lives of patients suffering from chronic pain and other disorders, Afferent Pharma aims to discover and develop novel small molecule drugs targeting specific ion channels and receptors involved in sensory and pain pathways.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

12 Patents

#72 in San Mateo, CA

#5,886 in California

#24,841 in US

#46,762 in the World

San Mateo, CA, United States of America

Afferent Pharmaceuticals, Inc.

Forward Citations = 27

9 inventors:

Anthony P Ford (12 out of 18 patents)

Prabha N Ibrahim (6 out of 134 patents)

Ronald Charles Hawley (6 out of 57 patents)

4. Joel R Gever (4 out of 5 patents)

5. Steven A Smith (3 out of 5 patents)

Please report any incorrect information to support@idiyas.com

Loading…